Innovator’s Pitch Challenge

Interested in Connecting? Please contact:

Gordon Hirschman
CEO
ghirschman@vivonics.com

Message the company or request a 1:1 meeting here

Company Description

At Vivonics, we are on a mission to enable on demand neurological insight and treatment across the neurological care spectrum. IPASS (Intracranial Pressure Assessment and Screening System), the first product that we are bringing to the market in pursuit of that mission, is a noninvasive medical device for continuous assessment of intracranial pressure (ICP). ICP increases due to a traumatic brain injury (TBI), stroke, idiopathic hypertension, various biological and viral pathogens, brain tumors, acute liver failure, and other, very common conditions. In current practice, ICP is only spot assessed or continuously monitored by invasive devices requiring surgical installation, like lumbar punctures and extra ventricular drains/bolts respectively. IPASS will provide a low-cost solution to quickly and easily assess ICP and continuously monitor for changes, allowing the physician to determine appropriate patient care without a highly invasive procedure, reducing costs, and improving outcomes.

Pitch Deck

Executive Summary